$2 Billion is the total value of Eventide Asset Management's 134 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 21.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Buy | CELGENE CORP | $84,119,000 | +14.6% | 702,400 | +3.5% | 4.20% | -1.4% |
| PANW | PALO ALTO NETWORKS INC | $64,027,000 | +2.4% | 363,500 | 0.0% | 3.20% | -11.9% | |
| LOW | LOWES COS INC | $55,540,000 | +10.3% | 730,400 | 0.0% | 2.78% | -5.1% | |
| LEA | LEAR CORP | $53,922,000 | +12.9% | 439,000 | 0.0% | 2.70% | -2.9% | |
| LRCX | Buy | LAM RESEARCH CORP | $52,757,000 | +21.9% | 664,275 | +0.2% | 2.64% | +4.9% |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $52,091,000 | +190.6% | 1,255,200 | +7.8% | 2.60% | +149.9% |
| RHT | Sell | RED HAT INC | $51,475,000 | +5.1% | 621,600 | -8.8% | 2.57% | -9.6% |
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $51,310,000 | -1.4% | 706,750 | +1.3% | 2.56% | -15.2% |
| ABBV | Buy | ABBVIE INC | $50,560,000 | +13.1% | 853,475 | +3.9% | 2.53% | -2.7% |
| EXR | EXTRA SPACE STORAGE INC | $47,651,000 | +14.3% | 540,200 | 0.0% | 2.38% | -1.7% | |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $45,183,000 | +9.9% | 522,650 | +0.2% | 2.26% | -5.5% |
| KAR | Buy | KAR AUCTION SVCS INC | $44,369,000 | +6.8% | 1,198,200 | +2.4% | 2.22% | -8.1% |
| XPO | Buy | XPO LOGISTICS INC | $44,099,000 | +56.2% | 1,618,300 | +36.6% | 2.20% | +34.3% |
| SPLK | Buy | SPLUNK INC | $38,709,000 | +10.4% | 658,200 | +3.9% | 1.94% | -5.0% |
| CYBR | Buy | CYBERARK SOFTWARE LTD | $37,159,000 | -6.0% | 823,200 | +4.4% | 1.86% | -19.2% |
| MBBYF | MOBILEYE N V AMSTELVEEN | $36,944,000 | -7.0% | 873,800 | 0.0% | 1.85% | -20.0% | |
| DATA | TABLEAU SOFTWARE INCcl a | $35,106,000 | +18.1% | 372,600 | 0.0% | 1.76% | +1.6% | |
| BLUE | Buy | BLUEBIRD BIO INC | $34,647,000 | -3.5% | 539,500 | +28.6% | 1.73% | -17.0% |
| PFPT | PROOFPOINT INC | $32,043,000 | +7.8% | 492,900 | 0.0% | 1.60% | -7.3% | |
| QLIK | Buy | QLIK TECHNOLOGIES INC | $31,844,000 | -11.1% | 1,005,800 | +2.3% | 1.59% | -23.5% |
| SCTY | Buy | SOLARCITY CORP | $31,382,000 | +97.1% | 615,100 | +65.0% | 1.57% | +69.6% |
| SYNA | SYNAPTICS INC | $31,373,000 | -2.6% | 390,500 | 0.0% | 1.57% | -16.2% | |
| SPWR | Buy | SUNPOWER CORP | $30,010,000 | +133.4% | 1,000,000 | +55.8% | 1.50% | +100.8% |
| MGA | Buy | MAGNA INTL INC | $29,459,000 | -13.0% | 726,300 | +3.0% | 1.47% | -25.1% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $29,326,000 | +36.0% | 1,066,400 | +9.3% | 1.47% | +17.0% |
| ASML | ASML HOLDING N V | $27,758,000 | +0.9% | 312,700 | 0.0% | 1.39% | -13.2% | |
| IDTI | Buy | INTEGRATED DEVICE TECHNOLOGY | $27,581,000 | +32.2% | 1,046,700 | +1.8% | 1.38% | +13.8% |
| STLD | STEEL DYNAMICS INC | $27,082,000 | +4.0% | 1,515,500 | 0.0% | 1.35% | -10.5% | |
| CPN | Buy | CALPINE CORP | $26,665,000 | +30.3% | 1,842,800 | +31.5% | 1.33% | +12.1% |
| TSLA | TESLA MTRS INC | $26,473,000 | -3.4% | 110,300 | 0.0% | 1.32% | -16.9% | |
| ATHN | Buy | ATHENAHEALTH INC | $26,430,000 | +241.7% | 164,192 | +183.1% | 1.32% | +194.2% |
| STKL | Buy | SUNOPTA INC | $26,215,000 | +108.3% | 3,832,600 | +48.0% | 1.31% | +79.2% |
| WBC | WABCO HLDGS INC | $26,138,000 | -2.5% | 255,600 | 0.0% | 1.31% | -16.1% | |
| WAB | WABTEC CORP | $24,892,000 | -19.2% | 350,000 | 0.0% | 1.24% | -30.5% | |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $24,480,000 | +19.7% | 475,800 | -0.9% | 1.22% | +3.0% |
| SGEN | Buy | SEATTLE GENETICS INC | $24,473,000 | +260.2% | 545,300 | +209.5% | 1.22% | +209.6% |
| MDVN | Buy | MEDIVATION INC | $23,401,000 | +17.8% | 484,100 | +3.6% | 1.17% | +1.4% |
| MGNX | Buy | MACROGENICS INC | $22,478,000 | +47.9% | 725,800 | +2.3% | 1.12% | +27.3% |
| IPHI | INPHI CORP | $21,592,000 | +12.4% | 799,100 | 0.0% | 1.08% | -3.3% | |
| BWA | BORGWARNER INC | $21,269,000 | +3.9% | 492,000 | 0.0% | 1.06% | -10.6% | |
| IMPV | Buy | IMPERVA INC | $20,379,000 | +0.5% | 321,900 | +3.9% | 1.02% | -13.5% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $19,528,000 | +13.0% | 300,800 | +22.8% | 0.98% | -2.8% |
| CBI | Buy | CHICAGO BRIDGE & IRON CO N V | $19,043,000 | +2.6% | 488,400 | +4.3% | 0.95% | -11.8% |
| NVAX | Buy | NOVAVAX INC | $18,288,000 | +23.3% | 2,179,700 | +3.9% | 0.91% | +6.0% |
| CAFD | Buy | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $18,045,000 | +409.0% | 1,118,000 | +234.6% | 0.90% | +337.9% |
| CSIQ | New | CANADIAN SOLAR INC | $17,376,000 | – | 600,000 | +100.0% | 0.87% | – |
| VCYT | Buy | VERACYTE INC | $16,214,000 | +63.2% | 2,252,000 | +6.3% | 0.81% | +40.4% |
| LOXO | Buy | LOXO ONCOLOGY INC | $15,741,000 | +165.5% | 553,300 | +63.1% | 0.79% | +128.8% |
| UFS | Buy | DOMTAR CORP | $14,780,000 | +25.9% | 400,000 | +21.8% | 0.74% | +8.4% |
| CRUS | New | CIRRUS LOGIC INC | $14,765,000 | – | 500,000 | +100.0% | 0.74% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $12,820,000 | +22.3% | 332,300 | +1.8% | 0.64% | +5.3% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $12,649,000 | +632350.0% | 423,750 | +423650.0% | 0.63% | – |
| ABY | Buy | ABENGOA YIELD PLC | $12,645,000 | +45060.7% | 655,500 | +38458.8% | 0.63% | +31500.0% |
| LLTC | LINEAR TECHNOLOGY CORP | $12,427,000 | +5.3% | 292,600 | 0.0% | 0.62% | -9.5% | |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $11,932,000 | +10.4% | 334,700 | +2.4% | 0.60% | -5.1% |
| EOG | EOG RES INC | $10,250,000 | -2.8% | 144,800 | 0.0% | 0.51% | -16.3% | |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $9,805,000 | -3.5% | 87,400 | -17.2% | 0.49% | -16.9% |
| TSRO | Buy | TESARO INC | $9,418,000 | +39.8% | 180,000 | +7.1% | 0.47% | +20.5% |
| KITE | Buy | KITE PHARMA INC | $9,157,000 | +17.5% | 148,600 | +6.1% | 0.46% | +1.1% |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $9,063,000 | +5.4% | 249,600 | +3.4% | 0.45% | -9.2% |
| AYR | AIRCASTLE LTD | $8,953,000 | +1.4% | 428,600 | 0.0% | 0.45% | -12.7% | |
| LGND | Sell | LIGAND PHARMACEUTICALS INC | $8,674,000 | -10.8% | 80,000 | -29.5% | 0.43% | -23.2% |
| PEGI | Buy | PATTERN ENERGY GROUP INCcl a | $8,551,000 | +21825.6% | 408,950 | +19848.8% | 0.43% | +21250.0% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $8,473,000 | +49.1% | 90,000 | +27.3% | 0.42% | +28.5% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $7,857,000 | -7.2% | 75,000 | -6.7% | 0.39% | -20.1% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $7,340,000 | +45.5% | 125,900 | +5.6% | 0.37% | +25.3% |
| CSLT | Buy | CASTLIGHT HEALTH INCcl b | $7,296,000 | +121.7% | 1,708,600 | +118.0% | 0.36% | +91.1% |
| NTUS | Buy | NATUS MEDICAL INC DEL | $7,155,000 | +33.4% | 148,900 | +9.5% | 0.36% | +14.7% |
| PRTA | Buy | PROTHENA CORP PLC | $7,138,000 | +80.6% | 104,800 | +20.2% | 0.36% | +55.2% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $7,071,000 | -27.8% | 125,000 | -49.2% | 0.35% | -38.0% |
| ONCE | Buy | SPARK THERAPEUTICS INC | $6,797,000 | +232.4% | 150,000 | +206.1% | 0.34% | +185.7% |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $6,693,000 | +36.8% | 498,000 | +42.9% | 0.34% | +18.0% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $6,593,000 | +173.3% | 420,500 | +83.8% | 0.33% | +135.7% |
| CERN | Buy | CERNER CORP | $6,510,000 | +6.9% | 108,200 | +6.5% | 0.32% | -8.2% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $6,493,000 | +184.4% | 246,500 | +130.4% | 0.32% | +144.4% |
| TGTX | Buy | TG THERAPEUTICS INC | $6,414,000 | +69.3% | 537,600 | +43.1% | 0.32% | +45.9% |
| MCRB | Buy | SERES THERAPEUTICS INC | $6,253,000 | +96.2% | 178,200 | +65.7% | 0.31% | +69.2% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $6,040,000 | -12.3% | 250,000 | -10.9% | 0.30% | -24.5% |
| XLRN | Buy | ACCELERON PHARMA INC | $6,022,000 | +177.6% | 123,500 | +41.8% | 0.30% | +138.9% |
| CEMP | Buy | CEMPRA INC | $5,756,000 | +31.9% | 184,900 | +17.9% | 0.29% | +13.4% |
| RGEN | Buy | REPLIGEN CORP | $5,715,000 | +15.0% | 202,000 | +13.2% | 0.29% | -1.0% |
| AGTC | Buy | APPLIED GENETIC TECHNOL CORP | $5,694,000 | +73.0% | 279,100 | +11.4% | 0.28% | +49.2% |
| VYGR | New | VOYAGER THERAPEUTICS INC | $5,475,000 | – | 250,000 | +100.0% | 0.27% | – |
| ORA | New | ORMAT TECHNOLOGIES INC | $5,471,000 | – | 150,000 | +100.0% | 0.27% | – |
| STML | Buy | STEMLINE THERAPEUTICS INC | $5,372,000 | -17.2% | 851,400 | +15.8% | 0.27% | -28.6% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $5,334,000 | +716.8% | 165,000 | +966.0% | 0.27% | +602.6% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $5,104,000 | -18.7% | 73,500 | +7.0% | 0.26% | -30.1% |
| XNCR | Sell | XENCOR INC | $5,029,000 | +12.2% | 344,000 | -6.2% | 0.25% | -3.8% |
| TCON | Buy | TRACON PHARMACEUTICALS INC | $4,784,000 | +21.2% | 517,700 | +28.2% | 0.24% | +4.4% |
| CDTX | Buy | CIDARA THERAPEUTICS INC | $4,530,000 | +103.0% | 264,000 | +50.5% | 0.23% | +73.8% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $4,475,000 | +72.8% | 377,000 | +19.6% | 0.22% | +49.3% |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $4,354,000 | – | 34,600 | +100.0% | 0.22% | – |
| OMED | Buy | ONCOMED PHARMACEUTICALS INC | $4,283,000 | +75.7% | 190,000 | +29.3% | 0.21% | +50.7% |
| ATRC | Sell | ATRICURE INC | $4,039,000 | +0.1% | 180,000 | -2.2% | 0.20% | -13.7% |
| JUNO | New | JUNO THERAPEUTICS INC | $3,957,000 | – | 90,000 | +100.0% | 0.20% | – |
| INSM | Buy | INSMED INC | $3,812,000 | +42.0% | 210,000 | +45.2% | 0.19% | +22.4% |
| IMDZ | Buy | IMMUNE DESIGN CORP | $3,614,000 | +91.7% | 180,000 | +16.5% | 0.18% | +64.5% |
| QURE | Buy | UNIQURE NV | $2,893,000 | -8.7% | 174,900 | +12.9% | 0.14% | -21.2% |
| CTMX | New | CYTOMX THERAPEUTICS INC | $2,087,000 | – | 100,000 | +100.0% | 0.10% | – |
| ARAY | Sell | ACCURAY INC | $2,067,000 | +13.5% | 306,200 | -16.0% | 0.10% | -2.8% |
| ZSAN | Buy | ZOSANO PHARMA CORP | $1,981,000 | -43.4% | 888,300 | +0.4% | 0.10% | -51.2% |
| INFI | Buy | INFINITY PHARMACEUTICALS INC | $1,937,000 | +16.3% | 246,700 | +25.2% | 0.10% | 0.0% |
| TNDM | TANDEM DIABETES CARE INC | $1,834,000 | +34.1% | 155,300 | 0.0% | 0.09% | +16.5% | |
| HASI | New | HANNON ARMSTRONG SUST INFR C | $1,665,000 | – | 88,000 | +100.0% | 0.08% | – |
| TTPH | Sell | TETRAPHASE PHARMACEUTICALS I | $1,397,000 | +7.6% | 139,300 | -19.9% | 0.07% | -6.7% |
| RGLS | Buy | REGULUS THERAPEUTICS INC | $1,400,000 | +33.3% | 160,600 | +0.1% | 0.07% | +14.8% |
| BBN | Buy | BLACKROCK TAX MUNICPAL BD TR | $303,000 | +104.7% | 14,450 | +96.6% | 0.02% | +66.7% |
| HTGC | Buy | HERCULES TECH GROWTH CAP INC | $277,000 | +145.1% | 22,700 | +102.7% | 0.01% | +100.0% |
| SEP | Buy | SPECTRA ENERGY PARTNERS LP | $255,000 | +133.9% | 5,350 | +98.1% | 0.01% | +116.7% |
| JCI | Buy | JOHNSON CTLS INC | $253,000 | +121.9% | 6,400 | +132.7% | 0.01% | +85.7% |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $267,000 | +128.2% | 11,750 | +108.0% | 0.01% | +85.7% |
| BDN | Buy | BRANDYWINE RLTY TRsh ben int new | $210,000 | +81.0% | 15,400 | +63.8% | 0.01% | +42.9% |
| BEP | Buy | BROOKFIELD RENEWABLE ENRGY Ppartnership unit | $194,000 | +181.2% | 7,400 | +196.0% | 0.01% | +150.0% |
| ERIC | Buy | ERICSSONadr b sek 10 | $180,000 | +104.5% | 18,700 | +107.8% | 0.01% | +80.0% |
| BAB | Buy | POWERSHARES ETF TR IIbuild amer etf | $180,000 | +20.0% | 6,211 | +21.5% | 0.01% | 0.0% |
| ETN | Buy | EATON CORP PLC | $182,000 | +136.4% | 3,500 | +133.3% | 0.01% | +125.0% |
| NYLD | Buy | NRG YIELD INCcl c | $156,000 | +164.4% | 10,600 | +107.8% | 0.01% | +166.7% |
| WELL | New | WELLTOWER INC | $136,000 | – | 2,000 | +100.0% | 0.01% | – |
| LPT | Buy | LIBERTY PPTY TRsh ben int | $115,000 | +101.8% | 3,700 | +105.6% | 0.01% | +100.0% |
| ABB | Buy | ABB LTDsponsored adr | $123,000 | +324.1% | 6,950 | +321.2% | 0.01% | +200.0% |
| SYK | Buy | STRYKER CORP | $121,000 | +116.1% | 1,300 | +116.7% | 0.01% | +100.0% |
| NSC | Buy | NORFOLK SOUTHERN CORP | $127,000 | +51.2% | 1,500 | +36.4% | 0.01% | +20.0% |
| CPPL | New | COLUMBIA PIPELINE PARTNERS L | $117,000 | – | 6,700 | +100.0% | 0.01% | – |
| BIP | New | BROOKFIELD INFRAST PARTNERSlp int unit | $83,000 | – | 2,200 | +100.0% | 0.00% | – |
| ITC | New | ITC HLDGS CORP | $90,000 | – | 2,300 | +100.0% | 0.00% | – |
| DLR | Buy | DIGITAL RLTY TR INC | $83,000 | +48.2% | 1,100 | +29.4% | 0.00% | +33.3% |
| TERP | Sell | TERRAFORM PWR INC | $58,000 | -99.7% | 4,650 | -99.6% | 0.00% | -99.7% |
| WBK | Buy | WESTPAC BKG CORPsponsored adr | $63,000 | +23.5% | 2,600 | +8.3% | 0.00% | 0.0% |
| GOV | New | GOVERNMENT PPTYS INCOME TR | $63,000 | – | 4,000 | +100.0% | 0.00% | – |
| LXP | Buy | LEXINGTON REALTY TRUST | $62,000 | +113.8% | 7,700 | +116.9% | 0.00% | +50.0% |
| NATI | Buy | NATIONAL INSTRS CORP | $60,000 | +114.3% | 2,100 | +110.0% | 0.00% | +50.0% |
| GLBL | Sell | TERRAFORM GLOBAL INCcl a | $49,000 | -98.9% | 8,700 | -98.7% | 0.00% | -99.2% |
| SE | Sell | SPECTRA ENERGY CORP | $35,000 | -58.8% | 1,450 | -55.4% | 0.00% | -60.0% |
| RMR | New | RMR GROUP INCcl a | $1,000 | – | 38 | +100.0% | 0.00% | – |
| HCN | Exit | HEALTH CARE REIT INC | $0 | – | -100 | -100.0% | 0.00% | – |
| AGM | Exit | FEDERAL AGRIC MTG CORPcl c | $0 | – | -700 | -100.0% | -0.00% | – |
| HCP | Exit | HCP INC | $0 | – | -1,470 | -100.0% | -0.00% | – |
| GNMA | Exit | ISHARES TRgnma bond etf | $0 | – | -3,203 | -100.0% | -0.01% | – |
| MDSO | Exit | MEDIDATA SOLUTIONS INC | $0 | – | -18,900 | -100.0% | -0.05% | – |
| CSII | Exit | CARDIOVASCULAR SYS INC DEL | $0 | – | -115,200 | -100.0% | -0.11% | – |
| SGMO | Exit | SANGAMO BIOSCIENCES INC | $0 | – | -482,500 | -100.0% | -0.16% | – |
| CMRE | Exit | COSTAMARE INC | $0 | – | -360,200 | -100.0% | -0.26% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -240,600 | -100.0% | -0.28% | – |
| PWR | Exit | QUANTA SVCS INC | $0 | – | -232,800 | -100.0% | -0.33% | – |
| ININ | Exit | INTERACTIVE INTELLIGENCE GRO | $0 | – | -210,200 | -100.0% | -0.36% | – |
| CGNX | Exit | COGNEX CORP | $0 | – | -205,000 | -100.0% | -0.41% | – |
| SUNEQ | Exit | SUNEDISON INC | $0 | – | -2,827,600 | -100.0% | -1.18% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -534,500 | -100.0% | -1.19% | – |
| DYAX | Exit | DYAX CORP | $0 | – | -1,450,300 | -100.0% | -1.61% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.